18F-Sodium Fluoride PET/CT Bone Imaging in Patients With Castration-Resistant Prostate Cancer and Bone Metastases

A Phase 2, Open-Label, Single-Arm Study of 18F-Sodium Fluoride PET/CT Bone Imaging in Enzalutamide-Treated Chemotherapy-Naïve Patients With Bone-Metastatic Castration-Resistant Prostate Cancer

Category & Conditions:
Cancer
Medicine:
Xtandi (enzalutamide)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
C3431012
Open Plain Language Summary Result:Click here